Reflecting on the first genetically engineered pig-to-human heart transplantation in this Clinical Outlook article, we discuss the likely future of cardiac xenotransplantation. Initial clinical trials are expected to explore compassionate use as destination therapy in carefully selected adult patients and as a bridge to heart allotransplantation in infant patients with complex congenital heart disease.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
First-of-its-kind Xenotransplantation: Bedarf an ethischer Reflexion in Wissenschaft und Gesellschaft
Ethik in der Medizin Open Access 03 February 2023
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Cooper, D. K. C. et al. Justification of specific genetic modifications in pigs for clinical organ xenotransplantation. Xenotransplantation 26, e12516 (2019).
Längin, M. et al. Consistent success in life-supporting porcine cardiac xenotransplantation. Nature 564, 430–433 (2018).
Goerlich, C. E. et al. The growth of xenotransplanted hearts can be reduced with growth hormone receptor knockout pig donors. J. Thorac. Cardiovasc. Surg. https://doi.org/10.1016/j.jtcvs.2021.07.051 (2021).
Bühler, L. et al. High-dose porcine hematopoietic cell transplantation combined with CD40 ligand blockade in baboons prevents an induced anti-pig humoral response. Transplantation 69, 2296–2304 (2000).
Yamamoto, T. et al. Old World Monkeys are less than ideal transplantation models for testing pig organs lacking three carbohydrate antigens (Triple-Knockout). Sci. Rep. 10, 9771 (2020).
Pierson, R. N. III, Burdorf, L., Madsen, J. C., Lewis, G. D. & D’Alessandro, D. A. Pig-to-human heart transplantation: Who goes first? Am. J. Transplant. 20, 2669–2674 (2020).
Byrne, G. W. Does human leukocyte antigens sensitization matter for xenotransplantation? Xenotransplantation 25, e12411 (2018).
John, M. & Bailey, L. L. Neonatal heart transplantation. Ann. Cardiothorac. Surg. 7, 118–125 (2018).
Cleveland, D. et al. The case for cardiac xenotransplantation in neonates: is now the time to reconsider xenotransplantation for hypoplastic left heart syndrome? Pediatr. Cardiol. 40, 437–444 (2019).
Li, Q. et al. Is sensitization to pig antigens detrimental to subsequent allotransplantation? Xenotransplantation 25, e12393 (2018).
Acknowledgements
Work on xenotransplantation in the authors’ laboratories is supported in part by NIH grants (AI090959 and AI153612) and a Department of Defense grant (W81XWH2010559).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
D.K.C.C. is a consultant for eGenesis, but the opinions expressed in this article are his own and do not necessarily reflect those of the company. D.K.C.C. and R.N.P.III have received research materials and/or funding from eGenesis and Revivicor.
Rights and permissions
About this article
Cite this article
Cooper, D.K.C., Pierson, R.N. The future of cardiac xenotransplantation. Nat Rev Cardiol 19, 281–282 (2022). https://doi.org/10.1038/s41569-022-00684-y
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41569-022-00684-y
This article is cited by
-
First-of-its-kind Xenotransplantation: Bedarf an ethischer Reflexion in Wissenschaft und Gesellschaft
Ethik in der Medizin (2023)
